First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation
Clinical trial NCT04006301 · COMPLETED
Trial details
- NCT number
- NCT04006301
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-26
- Primary completion
- 2020-07-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.